Global PCOS (Polycystic Ovary Syndrome) Treatment Markets, 2015-2019 & 2020-2025 by Surgery, Drug, Diagnosis, End User, Region, Forecast & Opportunities – ResearchAndMarkets.com

Global PCOS (Polycystic Ovary Syndrome) Treatment Markets, 2015-2019 & 2020-2025 by Surgery, Drug, Diagnosis, End User, Region, Forecast & Opportunities – ResearchAndMarkets.com




Global PCOS (Polycystic Ovary Syndrome) Treatment Markets, 2015-2019 & 2020-2025 by Surgery, Drug, Diagnosis, End User, Region, Forecast & Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global PCOS Treatment Market, Forecast & Opportunities, 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global PCOS Treatment Market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period.

The Global PCOS Treatment Market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, the development of new drugs and treatment options for the treatment of PCOS is expected to fuel the growth of the market through 2025.

The Global PCOS Treatment Market is segmented based on surgery, drug, diagnosis, End-user, company and region. Based on surgery, the market can be categorized into ovarian wedge resection, cyst aspiration and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years.

This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of segment across the globe.

Regionally, the Global PCOS Treatment Market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to dominate the Global PCOS Treatment Market owing to the growing prevalence of overweight and obese women population in the region.

Major players operating in the Global PCOS Treatment Market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others.

The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global PCOS Treatment Market

4. Executive Summary

5. Voice of Customer

6. Global PCOS Treatment Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling)

6.2.2. By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)

6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)

6.2.4. By End-user (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)

6.2.5. By Company (2019)

6.2.6. By Region

6.3. Product Market Map

7. Asia-Pacific PCOS Treatment Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Surgery

7.2.2. By Drug

7.2.3. By Diagnosis

7.2.4. By End-user

7.2.5. By Country

7.3. Asia-Pacific: Country Analysis

7.3.1. China PCOS Treatment Market Outlook

7.3.2. India PCOS Treatment Market Outlook

7.3.3. Australia PCOS Treatment Market Outlook

7.3.4. Japan PCOS Treatment Market Outlook

7.3.5. South Korea PCOS Treatment Market Outlook

8. Europe PCOS Treatment Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Surgery

8.2.2. By Drug

8.2.3. By Diagnosis

8.2.4. By End-user

8.2.5. By Country

8.3. Europe: Country Analysis

8.3.1. France PCOS Treatment Market Outlook

8.3.2. Germany PCOS Treatment Market Outlook

8.3.3. United Kingdom PCOS Treatment Market Outlook

8.3.4. Italy PCOS Treatment Market Outlook

8.3.5. Spain PCOS Treatment Market Outlook

9. North America PCOS Treatment Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Surgery

9.2.2. By Drug

9.2.3. By Diagnosis

9.2.4. By End-user

9.2.5. By Country

9.3. North America: Country Analysis

9.3.1. United States PCOS Treatment Market Outlook

9.3.2. Mexico PCOS Treatment Market Outlook

9.3.3. Canada PCOS Treatment Market Outlook

10. South America PCOS Treatment Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Surgery

10.2.2. By Drug

10.2.3. By Diagnosis

10.2.4. By End-user

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil PCOS Treatment Market Outlook

10.3.2. Argentina PCOS Treatment Market Outlook

10.3.3. Colombia PCOS Treatment Market Outlook

11. Middle East and Africa PCOS Treatment Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Surgery

11.2.2. By Drug

11.2.3. By Diagnosis

11.2.4. By End-user

11.2.5. By Country

11.3. MEA: Country Analysis

11.3.1. South Africa PCOS Treatment Market Outlook

11.3.2. Saudi Arabia PCOS Treatment Market Outlook

11.3.3. UAE PCOS Treatment Market Outlook

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Commonly Used PCOS Drugs to control different symptoms

15. Competitive Landscape

15.1. Bristol-Myers Squibb Company

15.2. Bayer AG

15.3. Pfizer, Inc.

15.4. Abbott Laboratories, Inc.

15.5. Merck & Co., Inc.

15.6. Sanofi SA

15.7. AstraZeneca PLC

15.8. Novartis AG

15.9. Teva Pharmaceutical Industries Limited

15.10. Ferring Pharmaceuticals, Inc.

16. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/i7slao

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900